Global Anti-Osteoporosis Therapy & Fracture Healing Market by Drug (Alendronate, Biophosphonates, Ibandronate), Route Of Administration (Injectable, Oral), Distribution - Cumulative Impact of High Inflation - Forecast 2023-2030- Product Image

Sale

Global Anti-Osteoporosis Therapy & Fracture Healing Market by Drug (Alendronate, Biophosphonates, Ibandronate), Route Of Administration (Injectable, Oral), Distribution - Cumulative Impact of High Inflation - Forecast 2023-2030

Report
255 Pages
May 2023
Region: Global
360iResearch™
ID: 5336746

UP TO €866EUR$895USD£748GBP OFF until Jun 30^th 2023

The Global Anti-Osteoporosis Therapy & Fracture Healing Market size was estimated at USD 12.73 billion in 2022, USD 13.80 billion in 2023, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.51% to reach USD 24.48 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Anti-Osteoporosis Therapy & Fracture Healing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Anti-Osteoporosis Therapy & Fracture Healing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug, the market is studied across Alendronate, Biophosphonates, Ibandronate, Risedronate, Selective Oestrogen Receptor Modulators, and Zoledronic Acid. The Selective Oestrogen Receptor Modulators is further studied across Raloxifene and Strontium Ranelete. The Alendronate is projected to witness significant market share during forecast period.
Based on Route Of Administration, the market is studied across Injectable and Oral. The Oral is projected to witness significant market share during forecast period.
Based on Distribution, the market is studied across Drug Stores, E-Commerce Market, Hospitals, Private Clinics, and Retail Pharmacies. The Private Clinics is projected to witness significant market share during forecast period.
Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.73% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Anti-Osteoporosis Therapy & Fracture Healing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Anti-Osteoporosis Therapy & Fracture Healing Market, including Arthrex, Inc., Bioventus Inc., DJO Global, Inc. by Colfax Corporation, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Isto Technologies II, LLC, Johnson & Johnson Services, Inc., Medtronic PLC, Novartis AG, Orthofix International N.V., Ossatec Benelux Ltd., Osteo-Pharma BV, Stryker Corporation, and Teva Pharmaceuticals Industries Ltd.

The report provides insights on the following pointers:

Market Penetration: Provides comprehensive information on the market offered by the key players
Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

What is the market size and forecast of the Global Anti-Osteoporosis Therapy & Fracture Healing Market?
What are the inhibiting factors and impact of COVID-19 shaping the Global Anti-Osteoporosis Therapy & Fracture Healing Market during the forecast period?
Which are the products/segments/applications/areas to invest in over the forecast period in the Global Anti-Osteoporosis Therapy & Fracture Healing Market?
What is the competitive strategic window for opportunities in the Global Anti-Osteoporosis Therapy & Fracture Healing Market?
What are the technology trends and regulatory frameworks in the Global Anti-Osteoporosis Therapy & Fracture Healing Market?
What is the market share of the leading vendors in the Global Anti-Osteoporosis Therapy & Fracture Healing Market?
What modes and strategic moves are considered suitable for entering the Global Anti-Osteoporosis Therapy & Fracture Healing Market?

Frequently Asked Questions about the Global Anti-Osteoporosis Therapy & Fracture Healing Market

What is the estimated value of the Global Anti-Osteoporosis Therapy & Fracture Healing Market?

The Global Anti-Osteoporosis Therapy & Fracture Healing Market was estimated to be valued at $12.73 Billion in 2022.

What is the growth rate of the Global Anti-Osteoporosis Therapy & Fracture Healing Market?

The growth rate of the Global Anti-Osteoporosis Therapy & Fracture Healing Market is 8.5%, with an estimated value of $24.48 Billion by 2030.

What is the forecasted size of the Global Anti-Osteoporosis Therapy & Fracture Healing Market?

The Global Anti-Osteoporosis Therapy & Fracture Healing Market is estimated to be worth $24.48 Billion by 2030.

Who are the key companies in the Global Anti-Osteoporosis Therapy & Fracture Healing Market?

Key companies in the Global Anti-Osteoporosis Therapy & Fracture Healing Market include Arthrex, Inc., Bioventus Inc., DJO Global, Inc. by Colfax Corporation, Eli Lilly and Company, F. Hoffmann, La Roche AG, GlaxoSmithKline plc, Isto Technologies II, LLC, Johnson & Johnson Services, Inc. and Medtronic PLC.

Report Attribute	Details
No. of Pages	255
Published	May 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 12.73 Billion
Forecasted Market Value ( USD ) by 2030	$ 24.48 Billion
Compound Annual Growth Rate	8.5%
Regions Covered	Global
No. of Companies Mentioned	15

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Anti-Osteoporosis Therapy & Fracture Healing Market, by Drug, 2022 vs 2030
4.3. Anti-Osteoporosis Therapy & Fracture Healing Market, by Route Of Administration, 2022 vs 2030
4.4. Anti-Osteoporosis Therapy & Fracture Healing Market, by Distribution, 2022 vs 2030
4.5. Anti-Osteoporosis Therapy & Fracture Healing Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising geriatric population worldwide
5.1.1.2. Rapid urbanization coupled with changing lifestyle is increasing the occurrence of bone diseases
5.1.1.3. Growing incidences of post-menopausal osteoporosis in women
5.1.2. Restraints
5.1.2.1. Probable side effects such as nausea, stomach ulcers and irritable bowel syndrome
5.1.3. Opportunities
5.1.3.1. Growing research and development in introduction of new drugs
5.1.3.2. Ongoing awareness of osteoporosis and its impact on health
5.1.4. Challenges
5.1.4.1. High cost of the healing and therapy
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Anti-Osteoporosis Therapy & Fracture Healing Market, by Drug

6.1. Introduction
6.2. Alendronate
6.3. Biophosphonates
6.4. Ibandronate
6.5. Risedronate
6.6. Selective Oestrogen Receptor Modulators
6.6.1. Raloxifene
6.6.2. Strontium Ranelete
6.7. Zoledronic Acid

7. Anti-Osteoporosis Therapy & Fracture Healing Market, by Route Of Administration

7.1. Introduction
7.2. Injectable
7.3. Oral

8. Anti-Osteoporosis Therapy & Fracture Healing Market, by Distribution

8.1. Introduction
8.2. Drug Stores
8.3. E-Commerce Market
8.4. Hospitals
8.5. Private Clinics
8.6. Retail Pharmacies

9. Americas Anti-Osteoporosis Therapy & Fracture Healing Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Anti-Osteoporosis Therapy & Fracture Healing Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Anti-Osteoporosis Therapy & Fracture Healing Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario

13. Company Usability Profiles

13.1. Arthrex, Inc.
13.2. Bioventus Inc.
13.3. DJO Global, Inc. by Colfax Corporation
13.4. Eli Lilly and Company
13.5. F. Hoffmann-La Roche AG
13.6. GlaxoSmithKline plc
13.7. Isto Technologies II, LLC
13.8. Johnson & Johnson Services, Inc.
13.9. Medtronic PLC
13.10. Novartis AG
13.11. Orthofix International N.V.
13.12. Ossatec Benelux Ltd.
13.13. Osteo-Pharma BV
13.14. Stryker Corporation
13.15. Teva Pharmaceuticals Industries Ltd.

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET RESEARCH PROCESS
FIGURE 2. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, 2022 VS 2030
FIGURE 3. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 4. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2022 VS 2030 (%)
FIGURE 5. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
FIGURE 6. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
FIGURE 7. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 8. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET DYNAMICS
FIGURE 9. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 10. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 11. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 12. AMERICAS ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 13. UNITED STATES ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 14. ASIA-PACIFIC ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 16. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 17. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 4. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 5. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ALENDRONATE, BY REGION, 2018-2030 (USD BILLION)
TABLE 6. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY BIOPHOSPHONATES, BY REGION, 2018-2030 (USD BILLION)
TABLE 7. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY IBANDRONATE, BY REGION, 2018-2030 (USD BILLION)
TABLE 8. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY RISEDRONATE, BY REGION, 2018-2030 (USD BILLION)
TABLE 9. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 10. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, BY REGION, 2018-2030 (USD BILLION)
TABLE 11. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY RALOXIFENE, BY REGION, 2018-2030 (USD BILLION)
TABLE 12. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY STRONTIUM RANELETE, BY REGION, 2018-2030 (USD BILLION)
TABLE 13. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ZOLEDRONIC ACID, BY REGION, 2018-2030 (USD BILLION)
TABLE 14. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 15. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD BILLION)
TABLE 16. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD BILLION)
TABLE 17. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 18. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD BILLION)
TABLE 19. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY E-COMMERCE MARKET, BY REGION, 2018-2030 (USD BILLION)
TABLE 20. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD BILLION)
TABLE 21. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD BILLION)
TABLE 22. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 23. AMERICAS ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 24. AMERICAS ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 25. AMERICAS ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 26. AMERICAS ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 27. AMERICAS ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 28. ARGENTINA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 29. ARGENTINA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 30. ARGENTINA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 31. ARGENTINA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 32. BRAZIL ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 33. BRAZIL ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 34. BRAZIL ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 35. BRAZIL ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 36. CANADA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 37. CANADA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 38. CANADA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 39. CANADA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 40. MEXICO ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 41. MEXICO ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 42. MEXICO ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 43. MEXICO ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 44. UNITED STATES ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY STATE, 2018-2030 (USD BILLION)
TABLE 45. UNITED STATES ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 46. UNITED STATES ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 47. UNITED STATES ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 48. UNITED STATES ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 49. ASIA-PACIFIC ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 50. ASIA-PACIFIC ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 51. ASIA-PACIFIC ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 52. ASIA-PACIFIC ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 53. ASIA-PACIFIC ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 54. AUSTRALIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 55. AUSTRALIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 56. AUSTRALIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 57. AUSTRALIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 58. CHINA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 59. CHINA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 60. CHINA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 61. CHINA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 62. INDIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 63. INDIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 64. INDIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 65. INDIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 66. INDONESIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 67. INDONESIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 68. INDONESIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 69. INDONESIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 70. JAPAN ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 71. JAPAN ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 72. JAPAN ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 73. JAPAN ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 74. MALAYSIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 75. MALAYSIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 76. MALAYSIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 77. MALAYSIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 78. PHILIPPINES ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 79. PHILIPPINES ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 80. PHILIPPINES ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 81. PHILIPPINES ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 82. SINGAPORE ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 83. SINGAPORE ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 84. SINGAPORE ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 85. SINGAPORE ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 86. SOUTH KOREA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 87. SOUTH KOREA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 88. SOUTH KOREA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 89. SOUTH KOREA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 90. TAIWAN ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 91. TAIWAN ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 92. TAIWAN ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 93. TAIWAN ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 94. THAILAND ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 95. THAILAND ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 96. THAILAND ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 97. THAILAND ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 98. VIETNAM ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 99. VIETNAM ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 100. VIETNAM ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 101. VIETNAM ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 107. DENMARK ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 108. DENMARK ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 109. DENMARK ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 110. DENMARK ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 111. EGYPT ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 112. EGYPT ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 113. EGYPT ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 114. EGYPT ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 115. FINLAND ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 116. FINLAND ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 117. FINLAND ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 118. FINLAND ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 119. FRANCE ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 120. FRANCE ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 121. FRANCE ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 122. FRANCE ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 123. GERMANY ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 124. GERMANY ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 125. GERMANY ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 126. GERMANY ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 127. ISRAEL ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 128. ISRAEL ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 129. ISRAEL ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 130. ISRAEL ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 131. ITALY ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 132. ITALY ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 133. ITALY ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 134. ITALY ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 135. NETHERLANDS ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 136. NETHERLANDS ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 137. NETHERLANDS ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 138. NETHERLANDS ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 139. NIGERIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 140. NIGERIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 141. NIGERIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 142. NIGERIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 143. NORWAY ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 144. NORWAY ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 145. NORWAY ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 146. NORWAY ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 147. POLAND ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 148. POLAND ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 149. POLAND ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 150. POLAND ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 151. QATAR ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 152. QATAR ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 153. QATAR ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 154. QATAR ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 155. RUSSIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 156. RUSSIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 157. RUSSIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 158. RUSSIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 159. SAUDI ARABIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 160. SAUDI ARABIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 161. SAUDI ARABIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 162. SAUDI ARABIA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 163. SOUTH AFRICA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 164. SOUTH AFRICA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 165. SOUTH AFRICA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 166. SOUTH AFRICA ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 167. SPAIN ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 168. SPAIN ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 169. SPAIN ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 170. SPAIN ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 171. SWEDEN ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 172. SWEDEN ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 173. SWEDEN ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 174. SWEDEN ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 175. SWITZERLAND ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 176. SWITZERLAND ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 177. SWITZERLAND ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 178. SWITZERLAND ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 179. TURKEY ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 180. TURKEY ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 181. TURKEY ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 182. TURKEY ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 183. UNITED ARAB EMIRATES ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 184. UNITED ARAB EMIRATES ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 185. UNITED ARAB EMIRATES ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 186. UNITED ARAB EMIRATES ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 187. UNITED KINGDOM ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DRUG, 2018-2030 (USD BILLION)
TABLE 188. UNITED KINGDOM ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY SELECTIVE OESTROGEN RECEPTOR MODULATORS, 2018-2030 (USD BILLION)
TABLE 189. UNITED KINGDOM ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD BILLION)
TABLE 190. UNITED KINGDOM ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD BILLION)
TABLE 191. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET, FPNV POSITIONING MATRIX, SCORES, 2022
TABLE 192. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET, FPNV POSITIONING MATRIX, BUSINESS STRATEGY, 2022
TABLE 193. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET, FPNV POSITIONING MATRIX, PRODUCT SATISFACTION, 2022
TABLE 194. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET RANKING, BY KEY PLAYER, 2022
TABLE 195. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 196. ANTI-OSTEOPOROSIS THERAPY & FRACTURE HEALING MARKET LICENSE & PRICING